MedPath

Oraverse Versus Laser

Phase 3
Conditions
Reversal of Local Anesthesia in Children
Interventions
Registration Number
NCT05473858
Lead Sponsor
sara nabil
Brief Summary

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Detailed Description

Patients will be divided randomly into two groups (20 patients in each group) Group (1): Patients will be undergoing anesthesia revision by diode laser Group (2): Patients will be undergoing anesthesia revision by oraverse. Then each group will be subdivided into 2 subgroups (10 patients each) according to type of local anesthetic agent into:

subgroup 1: Articaine 4% with 1:100000 epinephrin \&Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Patients who need to be treated under anesthesia by injecting mandibular first molar infiltration.
  2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laser groupdiode laserPatients will be undergoing anesthesia revision by diode laser
oraverse groupOraVerse Injectable ProductPatients will be undergoing anesthesia revision by oraverse
Primary Outcome Measures
NameTimeMethod
reversal of local anasthesia30 minute

patient free of lip numbness

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr.sara nabil

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath